Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Overweight and obesity: A second functional burden that amplifies gait vulnerability in early multiple sclerosis.
GLP-1 receptor agonists in multiple sclerosis: a systematic review of preclinical and clinical evidence.
scReGAT: Leveraging Knowledge of Regulatory Interactions to Predict Long-range Gene Regulation at Single-cell Resolution.
B cell CD19 is transferred between immune cells in mice and humans.
Cyberchondria severity in multiple sclerosis: the role of sociodemographic and clinical factors.
Physical disability, cognition, and depression as determinants of quality of life in multiple sclerosis: a cross-sectional study.
Analytical and Clinical Validity of a High-Throughput, Fully Automated Immunoassay for Plasma Neurofilament Light Chain.
A modified FLIT-B model of trigeminal neuralgia reveals anterior cingulate cortex involvement in anxiety-like behavior in mice.
Characterizing virtual community exercise programs for people with mobility limitations: a scoping review.
Associations of Physical Activity, Muscle Mass and Protein-Rich Food Consumption with Functional Fitness in Individuals with Multiple Sclerosis.
Artificial Intelligence Algorithm Based on Genetics to Predict Responses to Interferon-Beta Treatment in Multiple Sclerosis Patients.
Precision management of autoimmune ocular complications: Th17 mechanisms and therapeutic innovations.
Peptidylarginine deiminase 4-mediated citrullination in human disease: molecular mechanisms and therapeutic targeting.
Functional connectivity dynamics of monoaminergic circuits related to fatigue in multiple sclerosis.
Proteome-wide Mendelian Randomization and Colocalization Nominate CD58, PARP1, and Immune Co-stimulatory Pathways as Genetically Supported Targets for Multiple Sclerosis.
Drivers of Rising Prevalence in Major Motor Neurodegenerative Diseases: Temporal Trends in Sweden and France (2003-2022).
Multi-scale Radiomic Fingerprint: Quantifying Spatial Changes in Biology.
Comparable Infection Risk of Ocrelizumab and Rituximab in Multiple Sclerosis in a Nationwide Swedish Cohort Study.
Transcriptional Heterogeneity of Oligodendrocytes: Molecular Basis of Diversity Across Development, Brain Regions, and Neurological Diseases.
Folate and global health review series, part 4: syntheses on folate and autoimmune diseases and skeletal outcomes.
Adjunctive gypenosides for acute optic neuritis: A prematurely terminated randomized, double-blind, placebo-controlled pilot trial in a cohort with frequent AQP4-IgG positivity.
Thymus-derived myeloid programs track microglial tolerance states across human cohorts.
Dynamic single-cell transcriptomic analysis of peripheral blood mononuclear cells identifies novel biomarkers for autoimmune encephalitis.
Facial Expression Metrics as Digital Biomarkers of Neurologic Disease.
[Guidelines for the Management of Secondary Hypogammaglobulinemia in Multiple Sclerosis Patients on Anti-CD20 Monoclonal Antibody Therapy].

Pages